Eris Lifesciences Share Price, Technical, Fundamental Analysis, Financials, Shareholding, RSI, MACD and Moving Averages
Price on NSE
Price on BSE
Eris Lifesciences (ERIS (Bse Code: 540596)) Key Ratios
Eris Lifesciences Share Price Analysis API (Live)
Eris Lifesciences share price is ₹1,295.00, day high (share price) is ₹1,312.50, day low (share price) is ₹1,291.00 and volume is 48,468. 52 Week high share price for Eris Lifesciences is ₹1,820.00 on 18 Aug 2025 and 52 week low share price for Eris Lifesciences is ₹1,200.00 on 28 Apr 2026. Price data as of: 01 Sep, 2026 3:31 PM.
According to latest price data (as of 01 Sep, 2026 3:31 PM) for Eris Lifesciences share, 14 day period RSI (Relative Strength Index) is 31.5, 50 DMA (50 Displaced Moving Average) is 1,395.56 and 200 DMA (200 Displaced Moving Average) is 1,421.11.
Eris Lifesciences (ERIS) Technical Analysis
Eris Lifesciences Technical Data and Analysis available in multiple timeframes.
Eris Lifesciences Oscillators Analysis
Eris Lifesciences Price Action
Eris Lifesciences Oscillators Overview
| Indicator | Value |
|---|---|
| RSI (14) | 31.51 |
| Stoch %K (14, 3, 3) | 8.83 |
| CCI (20) | -114.48 |
| ADX (14) | 33.58 |
| Awesome Osc | -64.09 |
| Momentum (10) | -55.10 |
| MACD (12, 26, 9) | -26.48 |
| MACD Signal | -23.38 |
| Stoch RSI (14) | 5.14 |
| Williams %R (14) | -95.77 |
| Bull/Bear Power | -45.36 |
| Ultimate Osc | 39.01 |
| MFI (14) | 29.37 |
| ROC (21) | -6.38 |
| ROC (125) | -4.86 |
| ATR (14) | 30.74 |
Eris Lifesciences Moving Averages
| Ichimoku Base | 1,366.45 | Below Base |
| VWMA (20) | 1,349.84 | Below VWMA |
| HMA (9) | 1,298.76 | Below HMA |
Eris Lifesciences Technical SWOT Analysis
STRENGTHS
- No notable technical strength signals are currently observed.
WEAKNESSES
- Price is trading below the 200 DMA, indicating relatively weaker long-term structure.
- Price is below the 50 DMA, suggesting weaker medium-term positioning.
- MACD is below the signal line and in negative territory, reflecting downward momentum.
- RSI at 31.51 indicates weakening momentum.
OPPORTUNITIES
- No specific opportunity signals are identified; the setup appears neutral.
THREATS
- No immediate technical risk signals are identified.
Eris Lifesciences Daily Pivot Points (Support & Resistance)
| Level | Classic | Woodie's | Camarilla | Fibonacci |
|---|---|---|---|---|
| Resistance 3 | 1,342.13 | 1,339.20 | 1,304.90 | 1,331.07 |
| Resistance 2 | 1,331.07 | 1,329.60 | 1,302.33 | 1,320.37 |
| Resistance 1 | 1,314.13 | 1,311.20 | 1,299.77 | 1,313.76 |
| Pivot Point | 1,303.07 | 1,301.60 | 1,297.20 | 1,303.07 |
| Support 1 | 1,286.13 | 1,283.20 | 1,294.63 | 1,292.37 |
| Support 2 | 1,275.07 | 1,273.60 | 1,292.07 | 1,285.76 |
| Support 3 | 1,258.13 | 1,255.20 | 1,289.50 | 1,275.07 |
| Date | Close | ADX | PDI | MDI | Aroon Up | Aroon Down | Bollinger UB | Bollinger MB | Bollinger LB | CCI | CMF | MACD | Signal | MFI | PSAR | RSI (F) | RSI | Sto (F) %K | %D | Supertrend | Ult Osc | Wil %R |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing oscillators history... | ||||||||||||||||||||||
| Date | Close | SMA(5) | EMA(5) | SMA(8) | EMA(8) | SMA(9) | EMA(9) | SMA(10) | EMA(10) | SMA(12) | EMA(12) | SMA(20) | EMA(20) | SMA(21) | EMA(21) | SMA(26) | EMA(26) | SMA(30) | EMA(30) | SMA(34) | EMA(34) | SMA(50) | EMA(50) | SMA(100) | EMA(100) | SMA(150) | EMA(150) | SMA(200) | EMA(200) | Ichimoku Base | VWMA(20) | HMA(9) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing moving averages history... | ||||||||||||||||||||||||||||||||
Eris Lifesciences - Shareholding Pattern
Historical breakdown of ownership percentages over time.
| Category | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 54.14% | 53.92% | 54.85% | 54.85% |
| FII | 5.75% | 6.39% | 6.85% | 7.21% |
| DII (Other) | 1.84% | 2.13% | 2.06% | 2.03% |
| Retail & Others | 19.40% | 19.33% | 17.99% | 18.57% |
| Mutual Funds | 18.88% | 18.22% | 18.26% | 17.33% |
Eris Lifesciences - Yearly Income Statement (in ₹ Crore)
| Period | Revenue | Operating Profit | Net Profit |
|---|---|---|---|
| Mar 2026 | 3,137.17 +7.73% | 638.54 +30.62% | 647.51 +72.82% |
| Mar 2025 | 2,912.00 +43.24% | 488.87 +13.34% | 374.67 -5.65% |
| Mar 2024 | 2,032.97 +19.85% | 431.34 +6.6% | 397.12 +6.14% |
| Mar 2023 | 1,696.30 | 404.64 | 374.16 |
Eris Lifesciences - Corporate Actions
| Type | Ex-Date | Amount / Ratio | Details |
|---|---|---|---|
| Dividend | 29 May 2026 | ₹7.21 | View Details |
|
Announcement date
20 May 2026
Ex dividend date
29 May 2026
Record date
29 May 2026
Dividend type
Interim
Amount
7.21
Dividend %
721.0
Details
Rs.7.2100 per share(721%)Interim Dividend
|
|||
